A study using methylation-specific PCR to screen ovarian tumor samples for six tumor suppressor genes (BRCA1, RASSF1A, APC, p14ARF, p16INK4a, and DAP-kinase) indicated that this “hyper-methylation panel” provides diagnostic information in ovarian cancer. The gene discussed is CDKN2A; the disease is ovarian carcinoma.